BO-112 not checked

Highlight Therapeutics · anti-PD1 monoclonal antibody

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 2 trial completes
Trials
1 active
2 in total · 1 in the EU
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
How it’s given
“Noncoding double-stranded (ds) RNA based on polyinosinic-polycytidylic acid (Poly I:C), formulated with polyethylenimine (PEI) for intra-lesional injection”In the company’s words, NCT06422936 on ClinicalTrials.gov
Tested for
Basal Cell Carcinoma
Main trialPhase 2
“This is a multicenter, phase 2b, open-label, non-randomized, clinical trial to evaluate safety, tolerability, pharmacodynamics and preliminary efficacy of intra-lesional BO-112 in patients with resectable primary low and high risk basal cell carcinoma. * primary endpoint is composite visual and pathological response \[at surgery\] on patient level as assessed by central review * secondary endpoints are 1. Occurrence of adverse events (AEs), serious adverse events (SAEs), and AEs leading to discontinuation or death on patient level. 2. Pathological response \[at surgery\] on patient…”In the company’s words, NCT06422936 on ClinicalTrials.gov
Other names
anti-PD1 monoclonal antibody

Other drugs for Basal Cell Carcinoma

All 14 drugs for Basal Cell Carcinoma

Coming up1

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials2

TrialPhaseCompletesWhat it tests
Phase 2Active, not recruiting Dec 2026 Clinical Trial to Evaluate BO-112 in Patients With Basal Cell Carcinoma (BCC)
Phase 1Completed Jul 2020 Exploratory Study of BO-112 in Adult Patients With Aggressive Solid Tumors
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow BO-112

Following is part of Solo: you see every change to BO-112 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in